[Certain aspects of prevention and treatment of cutaneous melanoblastoma].
Podil'chak
M D
MD
Raspertov
V O
VO
Serbin
V V
VV
Krasivs'kiĭ
E Z
EZ
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000601:surgery*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy / Q000517:prevention & control / Q000601:surgery*; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D003609:Dactinomycin; D014750:Vincristine
Deiaki aspekty profilaktyky i likuvannia melanoblastomy shkiry.